COVID-19 Impact on Global Certolizumab pegol Market Size, Status and Forecast 2020-2026

July 2020 | 98 pages | ID: C94D9DEAF0CBEN
QYResearch

Abstracts

This report focuses on the global Certolizumab pegol status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Certolizumab pegol development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• UCB

Market segment by Type, the product can be split into

• Single-dose vial
• Single-dose prefilled syringe

Market segment by Application, split into

• Crohn’s disease
• Active rheumatoid arthritis
• Active psoriatic arthritis

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Certolizumab pegol status, future forecast, growth opportunity, key market and key players.
• To present the Certolizumab pegol development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Certolizumab pegol are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Certolizumab pegol Revenue
1.4 Market Analysis by Type
  1.4.1 Global Certolizumab pegol Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Single-dose vial
  1.4.3 Single-dose prefilled syringe
1.5 Market by Application
  1.5.1 Global Certolizumab pegol Market Share by Application: 2020 VS 2026
  1.5.2 Crohn’s disease
  1.5.3 Active rheumatoid arthritis
  1.5.4 Active psoriatic arthritis
1.6 Coronavirus Disease 2019 (Covid-19): Certolizumab pegol Industry Impact
  1.6.1 How the Covid-19 is Affecting the Certolizumab pegol Industry
    1.6.1.1 Certolizumab pegol Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Certolizumab pegol Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Certolizumab pegol Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Certolizumab pegol Market Perspective (2015-2026)
2.2 Certolizumab pegol Growth Trends by Regions
  2.2.1 Certolizumab pegol Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Certolizumab pegol Historic Market Share by Regions (2015-2020)
  2.2.3 Certolizumab pegol Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Certolizumab pegol Market Growth Strategy
  2.3.6 Primary Interviews with Key Certolizumab pegol Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Certolizumab pegol Players by Market Size
  3.1.1 Global Top Certolizumab pegol Players by Revenue (2015-2020)
  3.1.2 Global Certolizumab pegol Revenue Market Share by Players (2015-2020)
  3.1.3 Global Certolizumab pegol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Certolizumab pegol Market Concentration Ratio
  3.2.1 Global Certolizumab pegol Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Certolizumab pegol Revenue in 2019
3.3 Certolizumab pegol Key Players Head office and Area Served
3.4 Key Players Certolizumab pegol Product Solution and Service
3.5 Date of Enter into Certolizumab pegol Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Certolizumab pegol Historic Market Size by Type (2015-2020)
4.2 Global Certolizumab pegol Forecasted Market Size by Type (2021-2026)

5 CERTOLIZUMAB PEGOL BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Certolizumab pegol Market Size by Application (2015-2020)
5.2 Global Certolizumab pegol Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Certolizumab pegol Market Size (2015-2020)
6.2 Certolizumab pegol Key Players in North America (2019-2020)
6.3 North America Certolizumab pegol Market Size by Type (2015-2020)
6.4 North America Certolizumab pegol Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Certolizumab pegol Market Size (2015-2020)
7.2 Certolizumab pegol Key Players in Europe (2019-2020)
7.3 Europe Certolizumab pegol Market Size by Type (2015-2020)
7.4 Europe Certolizumab pegol Market Size by Application (2015-2020)

8 CHINA

8.1 China Certolizumab pegol Market Size (2015-2020)
8.2 Certolizumab pegol Key Players in China (2019-2020)
8.3 China Certolizumab pegol Market Size by Type (2015-2020)
8.4 China Certolizumab pegol Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Certolizumab pegol Market Size (2015-2020)
9.2 Certolizumab pegol Key Players in Japan (2019-2020)
9.3 Japan Certolizumab pegol Market Size by Type (2015-2020)
9.4 Japan Certolizumab pegol Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Certolizumab pegol Market Size (2015-2020)
10.2 Certolizumab pegol Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Certolizumab pegol Market Size by Type (2015-2020)
10.4 Southeast Asia Certolizumab pegol Market Size by Application (2015-2020)

11 INDIA

11.1 India Certolizumab pegol Market Size (2015-2020)
11.2 Certolizumab pegol Key Players in India (2019-2020)
11.3 India Certolizumab pegol Market Size by Type (2015-2020)
11.4 India Certolizumab pegol Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Certolizumab pegol Market Size (2015-2020)
12.2 Certolizumab pegol Key Players in Central & South America (2019-2020)
12.3 Central & South America Certolizumab pegol Market Size by Type (2015-2020)
12.4 Central & South America Certolizumab pegol Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 UCB
  13.1.1 UCB Company Details
  13.1.2 UCB Business Overview and Its Total Revenue
  13.1.3 UCB Certolizumab pegol Introduction
  13.1.4 UCB Revenue in Certolizumab pegol Business (2015-2020))
  13.1.5 UCB Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Certolizumab pegol Key Market Segments
Table 2. Key Players Covered: Ranking by Certolizumab pegol Revenue
Table 3. Ranking of Global Top Certolizumab pegol Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Certolizumab pegol Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Single-dose vial
Table 6. Key Players of Single-dose prefilled syringe
Table 7. COVID-19 Impact Global Market: (Four Certolizumab pegol Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Certolizumab pegol Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Certolizumab pegol Players to Combat Covid-19 Impact
Table 12. Global Certolizumab pegol Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Certolizumab pegol Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Certolizumab pegol Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Certolizumab pegol Market Share by Regions (2015-2020)
Table 16. Global Certolizumab pegol Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Certolizumab pegol Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Certolizumab pegol Market Growth Strategy
Table 22. Main Points Interviewed from Key Certolizumab pegol Players
Table 23. Global Certolizumab pegol Revenue by Players (2015-2020) (Million US$)
Table 24. Global Certolizumab pegol Market Share by Players (2015-2020)
Table 25. Global Top Certolizumab pegol Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Certolizumab pegol as of 2019)
Table 26. Global Certolizumab pegol by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Certolizumab pegol Product Solution and Service
Table 29. Date of Enter into Certolizumab pegol Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 32. Global Certolizumab pegol Market Size Share by Type (2015-2020)
Table 33. Global Certolizumab pegol Revenue Market Share by Type (2021-2026)
Table 34. Global Certolizumab pegol Market Size Share by Application (2015-2020)
Table 35. Global Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 36. Global Certolizumab pegol Market Size Share by Application (2021-2026)
Table 37. North America Key Players Certolizumab pegol Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Certolizumab pegol Market Share (2019-2020)
Table 39. North America Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 40. North America Certolizumab pegol Market Share by Type (2015-2020)
Table 41. North America Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 42. North America Certolizumab pegol Market Share by Application (2015-2020)
Table 43. Europe Key Players Certolizumab pegol Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Certolizumab pegol Market Share (2019-2020)
Table 45. Europe Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Certolizumab pegol Market Share by Type (2015-2020)
Table 47. Europe Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Certolizumab pegol Market Share by Application (2015-2020)
Table 49. China Key Players Certolizumab pegol Revenue (2019-2020) (Million US$)
Table 50. China Key Players Certolizumab pegol Market Share (2019-2020)
Table 51. China Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 52. China Certolizumab pegol Market Share by Type (2015-2020)
Table 53. China Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 54. China Certolizumab pegol Market Share by Application (2015-2020)
Table 55. Japan Key Players Certolizumab pegol Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Certolizumab pegol Market Share (2019-2020)
Table 57. Japan Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Certolizumab pegol Market Share by Type (2015-2020)
Table 59. Japan Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Certolizumab pegol Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Certolizumab pegol Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Certolizumab pegol Market Share (2019-2020)
Table 63. Southeast Asia Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Certolizumab pegol Market Share by Type (2015-2020)
Table 65. Southeast Asia Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Certolizumab pegol Market Share by Application (2015-2020)
Table 67. India Key Players Certolizumab pegol Revenue (2019-2020) (Million US$)
Table 68. India Key Players Certolizumab pegol Market Share (2019-2020)
Table 69. India Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 70. India Certolizumab pegol Market Share by Type (2015-2020)
Table 71. India Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 72. India Certolizumab pegol Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Certolizumab pegol Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Certolizumab pegol Market Share (2019-2020)
Table 75. Central & South America Certolizumab pegol Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Certolizumab pegol Market Share by Type (2015-2020)
Table 77. Central & South America Certolizumab pegol Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Certolizumab pegol Market Share by Application (2015-2020)
Table 79. UCB Company Details
Table 80. UCB Business Overview
Table 81. UCB Product
Table 82. UCB Revenue in Certolizumab pegol Business (2015-2020) (Million US$)
Table 83. UCB Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Certolizumab pegol Market Share by Type: 2020 VS 2026
Figure 2. Single-dose vial Features
Figure 3. Single-dose prefilled syringe Features
Figure 4. Global Certolizumab pegol Market Share by Application: 2020 VS 2026
Figure 5. Crohn’s disease Case Studies
Figure 6. Active rheumatoid arthritis Case Studies
Figure 7. Active psoriatic arthritis Case Studies
Figure 8. Certolizumab pegol Report Years Considered
Figure 9. Global Certolizumab pegol Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Certolizumab pegol Market Share by Regions: 2020 VS 2026
Figure 11. Global Certolizumab pegol Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Certolizumab pegol Market Share by Players in 2019
Figure 14. Global Top Certolizumab pegol Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Certolizumab pegol as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Certolizumab pegol Revenue in 2019
Figure 16. North America Certolizumab pegol Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Certolizumab pegol Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Certolizumab pegol Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Certolizumab pegol Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Certolizumab pegol Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Certolizumab pegol Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Certolizumab pegol Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. UCB Revenue Growth Rate in Certolizumab pegol Business (2015-2020)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed